Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXSB2400169	阿替利珠单抗注射液（皮下注射）	atezolizumab	Injection	Biological Products(2.2)	Supplementary Application	2024-12-14	Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG	view
JXSB2400168	阿替利珠单抗注射液（皮下注射）	atezolizumab	Injection	Biological Products(3.1)	Supplementary Application	2024-12-14	Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG	view
JXSS2400064	阿替利珠单抗注射液（皮下注射）	atezolizumab	Injection	Biological Products(2.2)	Import Drug Application	2024-07-27	Roche Diagnostics GmbH;Roche (China) Holding Ltd;Roche Registration GmbH	view
JXSS2400063	阿替利珠单抗注射液（皮下注射）	atezolizumab	Injection	Biological Products(3.1)	Import Drug Application	2024-07-27	Roche Diagnostics GmbH;Roche (China) Holding Ltd;Roche Registration GmbH	view